Sumitomo Chemical India Limited (NSE:SUMICHEM)
India · Delayed Price · Currency is INR 422.00
+8.40 (2.03%)
Feb 3, 2026, 3:29 PM IST
Sumitomo Chemical India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 32,340 | 31,485 | 28,439 | 35,110 | 30,612 | 26,449 | |
Revenue Growth (YoY) | 2.89% | 10.71% | -19.00% | 14.69% | 15.74% | 9.08% |
Cost of Revenue | 19,092 | 18,781 | 17,954 | 22,874 | 19,249 | 16,709 |
Gross Profit | 13,248 | 12,704 | 10,486 | 12,235 | 11,364 | 9,740 |
Selling, General & Admin | 3,215 | 3,157 | 2,758 | 2,691 | 2,447 | 2,322 |
Other Operating Expenses | 3,464 | 3,221 | 2,837 | 2,875 | 2,902 | 2,517 |
Operating Expenses | 7,341 | 7,044 | 6,362 | 6,087 | 5,797 | 5,304 |
Operating Income | 5,907 | 5,661 | 4,124 | 6,149 | 5,566 | 4,436 |
Interest Expense | -64.2 | -47.03 | -35.91 | -38.52 | -47.18 | -40.97 |
Interest & Investment Income | 822.82 | 822.82 | 589.97 | 249.35 | 103.55 | 99.52 |
Currency Exchange Gain (Loss) | 4 | 4 | 1.82 | 15.51 | -14.76 | -32.65 |
Other Non Operating Income (Expenses) | 622.57 | 361.89 | 347.48 | 168.1 | 143.24 | 71.19 |
EBT Excluding Unusual Items | 7,292 | 6,802 | 5,027 | 6,543 | 5,751 | 4,533 |
Gain (Loss) on Sale of Assets | - | - | 2.14 | - | 6.54 | 0.29 |
Asset Writedown | - | - | - | -1.32 | -0.28 | -0.01 |
Pretax Income | 7,131 | 6,802 | 5,029 | 6,542 | 5,757 | 4,533 |
Income Tax Expense | 1,817 | 1,738 | 1,332 | 1,520 | 1,522 | 1,079 |
Earnings From Continuing Operations | 5,314 | 5,064 | 3,697 | 5,022 | 4,235 | 3,454 |
Minority Interest in Earnings | -1.26 | -9.47 | -2.03 | - | 0.13 | -1.01 |
Net Income | 5,313 | 5,055 | 3,695 | 5,022 | 4,236 | 3,453 |
Net Income to Common | 5,313 | 5,055 | 3,695 | 5,022 | 4,236 | 3,453 |
Net Income Growth | 3.04% | 36.79% | -26.42% | 18.57% | 22.66% | 68.69% |
Shares Outstanding (Basic) | 499 | 499 | 499 | 499 | 499 | 499 |
Shares Outstanding (Diluted) | 499 | 499 | 499 | 499 | 499 | 499 |
EPS (Basic) | 10.65 | 10.13 | 7.40 | 10.06 | 8.49 | 6.92 |
EPS (Diluted) | 10.65 | 10.13 | 7.40 | 10.06 | 8.49 | 6.92 |
EPS Growth | 3.16% | 36.79% | -26.42% | 18.57% | 22.66% | 68.69% |
Free Cash Flow | - | 4,233 | 6,934 | 2,695 | 1,083 | 3,821 |
Free Cash Flow Per Share | - | 8.48 | 13.89 | 5.40 | 2.17 | 7.66 |
Dividend Per Share | - | 1.200 | 0.900 | 1.200 | 1.000 | 0.800 |
Dividend Growth | - | 33.33% | -25.00% | 20.00% | 25.00% | 45.45% |
Gross Margin | 40.96% | 40.35% | 36.87% | 34.85% | 37.12% | 36.82% |
Operating Margin | 18.27% | 17.98% | 14.50% | 17.51% | 18.18% | 16.77% |
Profit Margin | 16.43% | 16.05% | 12.99% | 14.30% | 13.84% | 13.05% |
Free Cash Flow Margin | - | 13.44% | 24.38% | 7.68% | 3.54% | 14.45% |
EBITDA | 6,361 | 6,095 | 4,533 | 6,471 | 5,823 | 4,741 |
EBITDA Margin | 19.67% | 19.36% | 15.94% | 18.43% | 19.02% | 17.93% |
D&A For EBITDA | 454.15 | 434.75 | 408.89 | 322.46 | 256.36 | 305.4 |
EBIT | 5,907 | 5,661 | 4,124 | 6,149 | 5,566 | 4,436 |
EBIT Margin | 18.27% | 17.98% | 14.50% | 17.51% | 18.18% | 16.77% |
Effective Tax Rate | 25.48% | 25.55% | 26.48% | 23.23% | 26.43% | 23.80% |
Revenue as Reported | 33,802 | 32,686 | 29,396 | 35,558 | 30,880 | 26,635 |
Advertising Expenses | - | 465.12 | 387.14 | 468.26 | 398.61 | 346.64 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.